We are live on ! Find out more
BENF icon

Beneficient

8 hedge funds and large institutions have $157M invested in Beneficient in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% more ownership

Funds ownership: 0%0.04% (+0.04%)

Holders
8
Holders Change
+8
Holders Change %
% of All Funds
0.13%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HIP
1
Hatteras Investment Partners
North Carolina
$148M +$240M +77,233 New
RCM
2
Rivernorth Capital Management
Florida
$8.02M +$12.1M +3,880 New
State Street
3
State Street
Massachusetts
$82.8K +$134K +43 New
Millennium Management
4
Millennium Management
New York
$57.3K +$93.2K +30 New
TRCT
5
Tower Research Capital (TRC)
New York
$54.9K +$90.1K +29 New
VF
6
Virtu Financial
New York
$43K +$71.5K +23 New
Citadel Advisors
7
Citadel Advisors
Florida
$34.7K +$55.9K +18 New
Bank of America
8
Bank of America
North Carolina
$1.68K +$3.11K +1 New
UBS Group
9
UBS Group
Switzerland
$672

BENF Hedge Fund Activity: Q2 2023 in Review

8 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Beneficient (BENF) for Q2 2023, worth a combined $157M.

Buyers outnumbered sellers: 8 funds opened new BENF positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Rivernorth Capital Management, opening a new position worth an estimated $12.1M.

  • 8 institutional investors held Beneficient (BENF) as of Q2 2023, up from 0 in Q1 2023.
  • Funds reported $157M of Beneficient stock for Q2 2023.
  • 8 funds opened new Beneficient positions in Q2 2023 and 0 closed out, a net change of +8 holders.
  • The largest Beneficient buyer in Q2 2023 was Rivernorth Capital Management, an estimated $12.1M added.

Based on aggregated 13F filings for Q2 2023.